Bing Z. Carter

Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA

Biography

Dr. Carter joined the Section of Molecular Hematology and Therapy in the Department of Leukemia in 1999. Since then, her research has been focused on understanding the regulation of apoptotic regulators and targeting antiapoptotic proteins as a strategy to induce apoptosis in myeloid leukemia. Supported by AML PO-1, Dr. Carter found that survivin and XIAP, members of inhibitors of apoptosis protein family (IAPs) are highly expressed in AML and are potential therapeutic targets for AML.

Research Interest

Research interest includes the 2-tert-butyl-1,4-benzoquinone Induces Apoptosis in Chronic Myeloid Leukemia Cells Resistant to Imatinib via Inducing Caspase-Dependent Bcr- Abl Downregulation

Relevant Topics

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 6627

Medicinal Chemistry received 6627 citations as per Google Scholar report

Medicinal Chemistry peer review process verified at publons

Indexed In

CAS Source Index (CASSI)
Index Copernicus
Google Scholar
Sherpa Romeo
Open J Gate
Genamics JournalSeek
ResearchBible
China National Knowledge Infrastructure (CNKI)
RefSeek
Directory of Research Journal Indexing (DRJI)
Hamdard University
EBSCO A-Z
OCLC- WorldCat
Scholarsteer
Publons
Euro Pub

Medicinal Chemistry